SCHEMBL22708356

SCHEMBL22708356

c1ccc(-c2ccc3c(c2)oc2c3c3ccccc3c3c4ccccc4n(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.34
MAPT P10636 6/20 0.33
ALDH1A1 P00352 5/20 0.33
HPGD P15428 3/20 0.33
TSHR P16473 2/20 0.33
PGR P06401 1/20 0.32
KDM4E B2RXH2 3/20 0.31
LMNA P02545 3/20 0.31
GAA P10253 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MAPK1 P28482 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 4/20 0.31
KMT2A Q03164 4/20 0.31
POLB P06746 2/20 0.31
NPSR1 Q6W5P4 2/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22199932 0.92 MAPT (0.39) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22199809 0.92 MAPT (0.39) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22199913 0.91 MAPT (0.36) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22708874 0.91 ALDH1A1 (0.37) PRKDCMAPTALDH1A1HPGDTSHR
SCHEMBL17427569 0.89 MAPT (0.40) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22199914 0.89 ALDH1A1 (0.36) MAPTALDH1A1HPGDTSHRPGR
SCHEMBL22708875 0.88 PRKDC (0.36) PRKDCMAPTALDH1A1HPGDTSHR
SCHEMBL22708517 0.87 ALDH1A1 (0.41) PRKDCMAPTALDH1A1HPGDKDM4E
SCHEMBL22708748 0.87 ALDH1A1 (0.41) PRKDCMAPTALDH1A1HPGDKDM4E
SCHEMBL19428545 0.87 PRKDC (0.33) PRKDCMAPTALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 PRKDC 4444/4885MAPT 1801/4885ALDH1A1 11/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 PRKDC 4444/4885MAPT 1801/4885ALDH1A1 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.